Watch INSP. Know when insiders buy.
One email the day a filing lands. Free.
INSP
Inspire Medical Systems, Inc.
72.74
−0.01 −0.01%
USD · close Sep 17
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
99
PASS · shorts 99
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.1BP/E 16.0DIV YIELD —FCF YIELD 5.57%REV TTM $898.7M +4.3%NET INCOME $135M +154.2%NET CASH $106.4M52W 40.05 – 143.99SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $200.6M | −7.6% | 85.5% | −$514K | $314K | — | 0.01 | $23.2M | $9.2M | $14.1M | Aug 3 |
| Q1 2026 · Mar 31 | $204.6M | +1.6% | 86.5% | −$1.1M | −$11.3M | −477.5% | -0.39 | $12.8M | $9.7M | $3.1M | Aug 3 |
| Q4 2025 · Dec 31derived | $269.1M | +12.2% | 86.6% | $46.1M | $136.1M | +286.4% | 4.58 | $52.5M | $10.7M | $41.8M | Feb 13 |
| Q3 2025 · Sep 30 | $224.5M | +10.5% | 85.8% | $9.6M | $9.9M | −46.3% | 0.34 | $68.5M | $10.4M | $58.1M | Nov 3 |
| Q2 2025 · Jun 30 | $217.1M | +10.8% | 84.0% | −$3.3M | −$3.6M | −136.7% | -0.12 | $2.7M | $9M | −$6.3M | Aug 3 |
| Q1 2025 · Mar 31 | $201.3M | +22.7% | 84.7% | −$1.5M | $3M | — | 0.10 | −$6.7M | $8.4M | −$15.1M | Aug 3 |
| Q4 2024 · Dec 31derived | $239.7M | +24.5% | 85.0% | $31.9M | $35.2M | +138.6% | 1.15 | $69.2M | $7M | $62.2M | Feb 13 |
| Q3 2024 · Sep 30 | $203.2M | +32.5% | 84.1% | $14.3M | $18.5M | — | 0.60 | $52.3M | $8M | $44.3M | Nov 3 |
| Q2 2024 · Jun 30 | $195.9M | — | 84.8% | $5.1M | $9.8M | — | 0.32 | −$78K | $12.4M | −$12.5M | Nov 3 |
| Q1 2024 · Mar 31 | $164M | — | 84.9% | −$15.2M | −$10M | — | -0.34 | $8.9M | $11.7M | −$2.8M | Nov 3 |
| Q4 2023 · Dec 31derived | $192.5M | — | 85.4% | $9.3M | $14.8M | — | 0.51 | $17.3M | $8M | $9.2M | Feb 13 |
| Q3 2023 · Sep 30 | $153.3M | — | 84.1% | −$13.5M | −$8.5M | — | -0.29 | $3.6M | $7M | −$3.4M | Nov 4 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $912M | 85.4% | $51M | $145.4M | 15.9% | 4.89 | $117M | $38.5M | $78.5M | $175M | — |
| FY2024 · to Dec 31 | $802.8M | 84.7% | $36.1M | $53.5M | 6.7% | 1.75 | $130.2M | $39.1M | $91.1M | $0 | — |
| FY2023 · to Dec 31 | $624.8M | 84.5% | −$40.3M | −$21.2M | -3.4% | -0.72 | $24.7M | $23.6M | $1M | $0 | — |
| FY2022 · to Dec 31 | $407.9M | 83.8% | −$47.6M | −$44.9M | -11.0% | -1.60 | $11.6M | $9.1M | $2.5M | $0 | — |
| FY2021 · to Dec 31 | $233.4M | 85.7% | −$39.9M | −$42M | -18.0% | -1.54 | −$20.1M | $4.7M | −$24.8M | — | — |
| FY2020 · to Dec 31 | $115.4M | 84.7% | −$56.2M | −$57.2M | -49.6% | -2.19 | −$53M | $2.5M | −$55.5M | — | — |
Every number comes from Inspire Medical Systems, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.